Annals of Pharmacy Education, Safety, and Public Health Advocacy is a peer-reviewed, double-blind international journal devoted to the publication of cutting-edge clinical research in the field of oncology. With an unwavering focus on clinical aspects of cancer, this journal serves as a trusted platform for the dissemination of original studies, critical reviews, and innovative findings that deepen our understanding of cancer diagnosis, treatment, prognosis, and patient care.
Our scope embraces all dimensions of clinical cancer research, including but not limited to cancer biology, pathology, genetics, immunology, novel therapeutic approaches, and advances in clinical trials. By encouraging collaboration among clinicians, researchers, and healthcare professionals across Asia and beyond, we aim to contribute to the global fight against cancer through the promotion of evidence-based practices and translational research.
Published biannually, the Annals of Pharmacy Education, Safety, and Public Health Advocacy remains committed to upholding the highest standards of academic integrity, scientific rigor, and relevance—dedicated to improving patient outcomes and shaping the future of clinical oncology.
Publishing Schedule
The Journal is published biannually, in June and December.
If you have any questions, please contact us at: [email protected]
